The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
IL-11 is a crucial determinant of cardiovascular fibrosis
Open accessAbstract
Fibrosis is a common pathology in cardiovascular disease. In the heart, fibrosis causes mechanical and electrical dysfunction and in the kidney, it predicts the onset of renal failure. Transforming growth factor β1 (TGFβ1) is the principal pro-fibrotic factor, but its inhibition is associated with side effects due to its pleiotropic roles. We hypothesized that downstream effectors of TGFβ1 in fibroblasts could be attractive therapeutic targets and lack upstream toxicity. Here we show, using integrated imaging-genomics analyses of primary human fibroblasts, that upregulation of interleukin-11 (IL-11) is the dominant transcriptional response to TGFβ1 exposure and required for its pro-fibrotic effect. IL-11 and its receptor (IL11RA) are expressed specifically in fibroblasts, in which they drive non-canonical, ERK-dependent autocrine signalling that is required for fibrogenic protein synthesis. In mice, fibroblast-specific Il11 transgene expression or Il-11 injection causes heart and kidney fibrosis and organ failure, whereas genetic deletion of Il11ra1 protects against disease. Therefore, inhibition of IL-11 prevents fibroblast activation across organs and species in response to a range of important pro-fibrotic stimuli. These results reveal a central role of IL-11 in fibrosis and we propose that inhibition of IL-11 is a potential therapeutic strategy to treat fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microbiota driven intestinal fibrosis may be mediated by induction of the IL-33 receptor ST2 on epithelial cells157 or the pro-fibrotic action of tumor necrosis factor-like cytokine 1A (TL1A)158”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,682
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Cited by
Sorted by citations
Items 601–645 of 645
Generation and characterization of the Il11-Cre knock-in mouse
Zhou, X. E., Xie, Z., Liu, W., Wang, Q., Lin, H., Li, R., Lang, Y., Chen, J., Yang, X. Y., Teng, Y., et al. (2026) · Transgenic Research · doi:10.1007/s11248-026-00491-y
Font, J., Dolladille, C., Divoux, J., Chrétien, B., de BOYSSON, H., Legallois, D., Ollitrault, P., Champ‐Rigot, L., Ferchaud, V., Pellissier, A., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2024-098166
Badyal, R., Kohlen, B., Keen, K. J., Dunne, J. V., & Hackett, T. (2026) · Cells · doi:10.3390/cells15080671 · Cited by 2
Luo, K., S, Y., Zhang, Y., Zi, Y.-F., Guo, G., Chen, X., Feng, W., Jing, Q., Li, L., Han, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-47797-9
Luo, G., Hu, W., Yang, J., Lu, Z., Cui, Y., Zeng, W., Ding, H., Li, Q., Chen, Z., Tong, X., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08637-w
Schmitt, A.-M., Rohringer, S., Specht, S. J., Topcu, S., Grasl, C., Schima, H., Prückler, M., Walter, I., Podesser, B. K., & Bergmeister, H. (2026) · Biomaterials Research · doi:10.34133/bmr.0372
CDCP1 Deletion Protects Against Pressure Overload-Induced Cardiac Dysfunction and Fibrosis in MicePreprint
Pereira, N., Ghazal, R., Srinivas, A. N., wang, M., Cao, J. J. L., Wang, L., Marín-Goñi, I., Sherman, W., John, A., Vyas, H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9236741/v1
Self-citationLoss of Cyclin G–Associated Kinase Leads to Lysosome Dysfunction and Immune Modulation in Podocytes
Bunda, P., Tian, X., Nagata, S., Lerner, G., Rangel, P. X. M., Gu, J., Zhao, H., Greene, L. E., Ferguson, S. M., Inoue, K., et al. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000001130
Targeting fibrosis in the treatment of lower urinary tract dysfunction
Limkar, A. R., Vrba, S. M., Ricke, E. A., Fábry, Z., Lee, M., McVary, K. T., & Ricke, W. A. (2026) · The Journal of Pathology · doi:10.1002/path.70079
Liang, G., Lin, Y., Li, L., Cai, J., & Liu, X. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179050
Cellular senescence in Crohn’s disease: a double-edged sword in intestinal fibrosis
Liu, J., & Yu, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1825690
Zhang, F., Liu, Y. H., Liu, R., Li, B., & Li, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1801258
Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy
Jordan, M., Stucki-Koch, A., Schinke, M., Willmer, L., Senne, I., Abbas, N., Bentele, M., Oldenkott, D., Lachmann, N., Feldbrügge, L., et al. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02695-5
Cytokines with pro- and antiinflammatory activities
Dembić, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45128-7.00015-7
Li, X.-F., Sun, Y., Wang, W., Bao, Z.-Y., Zhong, Y.-Z., Chen, H., Yu, D., Zhu, C., Ni, J., & Zhu, B. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-026-01188-y
Beyond fibrosis: Emerging role of IL-11 in regulating innate and adaptive immune cell plasticity
Zhang, Y., Chen, J., & Gong, L. H. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12443-0
IL-1–Activated Inflammatory Cardiac Fibroblasts Exacerbate Acute Coxsackievirus B3 Myocarditis
Elias, D. S., Jo, W., Talor, M. V., Jaime, C. M., Daoud, A. R., Sulkaj, I., Květoň, M., Wang, N., Fabián, O., Melenovský, V., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101637
Liu, R. G., Liu, Z., Wang, P., Zhang, Y., Hou, S., Zhang, C., Guan, W., Wang, S., Sun, X., Zhao, C., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10121104/v1
Metabolic reprogramming in cardiac fibrosis: mechanisms, crosstalk, and therapeutic interventions
Wang, X. Y., Wang, X. Y., Guo, F., Ding, Q., & Jin, H. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1811882
Chronic Kidney Disease-Associated Cardiomyopathy: Mechanisms and Therapeutic Strategies
Grigoriou, K., Lamprou, V., Chatzichidiroglou, A., Theofilis, P., Iliakis, P., Apostolos, A., Ktenopoulos, N., Karagiannidis, E., Antoniadis, A. P., Fragakis, N., et al. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm51534
Targeting Fibroblast Activation Protein for Precision Medicine
Liu, J., Zhao, X., Liu, P., Yu, J., Chen, X. S., & Zhang, J. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00139
Long, T., Ma, J., Hu, W., Wang, Q., Xie, Z., Wu, S., & Wu, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167075
Wang, L., Zhu, L., Peng, S., Zheng, Q., Zhang, Q., Chen, Y., Lu, Y., & Deng, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1764404
Gaete-Argel, A., Ananías-Sáez, C., Rojas-Fuentes, C., Giraldo-Ocampo, S., Jara, D., Hernández‐Díaz, T., Ortega-Orellana, C., López-Palma, D., Akiyama, H., Gummuluru, S., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1912292
Wang, M., Qian, Y., Huang, E., Chu, C., Gao, T., Chen, S., Zhao, N., Luo, C., Liu, Y., Zheng, X., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1911726
Self-citationYang, Y., Zhang, H., Du, J., Sun, W. C., Peng, X., & Fan, J. (2026) · Advanced Materials · doi:10.1002/adma.74615
Pohl, P. C., Zapotoski, L. N. K., Sardinha, L. R., Villas-Boas, I. M., Pidde, G., & Tambourgi, D. V. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1880784
Sanwlani, R., Thompson, G. H., Bramich, K., Ang, C., Trowbridge, M., Duringer, C. E., Stolojan, V., Davidson, S. M., Savvatis, K., McVey, J. H., et al. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70362
Liao, J., Gan, L., Lü, L., Ouyang, L., Xiong, Y., Al-Smadi, F., Dai, G., Shahbazi, M., Mi, B., Liu, M., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71700
New approach methodologies: drug screening platform to identify antifibrotic compounds
Zhang, H., Ren, L., Huang, R., Tan, R., Solow-Cordero, D. E., Mukherjee, S., & Wu, J. C. (2026) · Nature Protocols · doi:10.1038/s41596-026-01445-8
Hao, T., Li, J., Amancherla, K. V., Sun, L., Gokulnath, P., Patino-Guerrero, A., Sharma, R., Garcia‐Mansfield, K., Xiao, C., Manning, A. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.28.755177
Luo, Y., Kang, A., Zhang, G., Xu, Y., Zhang, T., & Wu, X. (2026) · Clinical Science · doi:10.1042/cs20260881
Cardiac nanomedicine for ischemic injury and remodeling: imaging and therapy
Zhang, W., Zeng, X.-L., Himly, M., Li, Y., & Zhang, G. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2742413
Yang, L., Huang, Y., Liu, A., Yan, Y., Liu, B., & Yuan, X. (2026) · Biomedicines · doi:10.3390/biomedicines14102265
Shores, K. L., Gao, X. D., Liu, D. R., & Truskey, G. A. (2026) · Science Advances · doi:10.1126/sciadv.aeh3785
Development of a Lactam-Bridged Peptide as Interleukin-11 Antagonist for Renal Fibrosis Treatment
Yang, X., Zhao, N., Zheng, R., Li, J., Wu, Y., Ma, Z., Pang, N., Meng, X., Liu, R., Xiong, X., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00034
Deb, D., Ray, S., Sharma, P., Sharma, P., & Sikder, K. (2026) · Chronobiology International · doi:10.1080/07420528.2026.2745644
Chen, H., & Liang, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1951110
Park, I. G., Song, L., Cho, J., Noh, M., & Sung, J. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2749519
Shin, H. J., Park, H.-Y. L., & Park, C. K. (2026) · British Journal of Ophthalmology · doi:10.1136/bjo-2026-330371
Yu, Z., Dong, X., Li, F., Zhang, Y., Dai, S., Cao, N., Jia, X., Zhao, J., Wang, B., Chang, W., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.10.024
Translational biology of human cardiac fibrosis
Parvathaneni, A., Lavine, K. J., & Priest, J. R. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00891-7
Design of full-length agonist and antagonist antibodies for hard targetsPreprint
Aglietti, R. A., Ansari, R., Bowers, P. M., Buelles, T.-H., Chauvin, H., Duplay, T. M., Hibouri, M. E., Jorda, J., Laniado, J., Malago, M. M. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.21.760573
BindingDB Entry 50023282: De novo discovery of cyclic peptide inhibitors of IL-11 signaling.
BindingDB (2026) · UC San Diego · doi:10.7270/q2v129qm
Rethinking inflammaging: Spatiotemporal decoupling and the failure of inflammatory regulation
Deng, X., Wang, L., Luo, M., & Wu, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103438
Metadata
- Authors
- Schafer, S., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Moreno-Moral, A., DeLaughter, D. M., Ng, B., Patone, G., Chow, K., Khin, E., Tan, J., Chothani, S. P., Ye, L., Rackham, O. J. L., Ko, N. S. J., Sahib, N. E., Pua, C. J., Zhen, N. T. G., Xie, C., Wang, M., Maatz, H., Lim, S., Saar, K., Blachut, S., Petretto, E., Schmidt, S., Putoczki, T., Guimarães-Camboa, N., Wakimoto, H., van Heesch, S., Sigmundsson, K., Lim, S. L., Soon, J. L., Chao, V. T. T., Chua, Y. L., Tan, T. E., Evans, S. M., Loh, Y. J., Jamal, M. H., Ong, K. K., Chua, K. C., Ong, B.-H., Chakaramakkil, M. J., Seidman, J. G., Seidman, C. E., Hubner, N., Sin, K. Y. K., & Cook, S. A.
- Affiliations
- National University of Singapore (SG)
- National Heart Centre Singapore (SG)
- Harvard University (US)
- Max Delbrück Center (DE)
- The University of Melbourne (AU)
- KK Women's and Children's Hospital (SG)
- Brigham and Women's Hospital (US)
- Corresponding author
- Cook, Stuart A.
- ORCID
- Viswanathan, Sivakumar
- Widjaja, Anissa A.
- Lim, Wei-Wen
- DeLaughter, Daniel M.
- Ng, Benjamin
- Patone, Giannino
- Chow, Kingsley
- Chothani, Sonia P.
- Ye, Lei
- Rackham, Owen J. L.
- Pua, Chee Jian
- Xie, Chen
- Wang, Mao
- Maatz, Henrike
- Saar, Kathrin
- Blachut, Susanne
- Petretto, Enrico
- Schmidt, Sabine
- Putoczki, Tracy
- Wakimoto, Hiroko
- Chao, Victor T. T.
- Chua, Yeow L.
- Loh, Yee J.
- Jamal, Muhammad H.
- Ong, Boon-Hean
- Chakaramakkil, Mathew J.
- Seidman, Jonathan G.
- Seidman, Christine E.
- Sin, Kenny Y. K.
- Cook, Stuart A.
- Venue
- Nature
- Published
- 2017-11-13
- Volume
- 552
- Issue
- 7683
- Pages
- 110-115
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5807082
- OpenAlex
- W2770331207
- Cited by
- 639
- References
- 42
- Citations by year
- 2026: 75 · 2025: 74 · 2024: 79 · 2023: 81 · 2022: 87 · 2021: 81 · 2020: 80 · 2019: 50 · 2018: 28 · 2017: 3
- FWCI
- 33.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- National University of Singapore (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institutes of Health (DP1OD006428)
- National Heart, Lung, and Blood Institute (R01HL070867, DP1HL117649, R01HL080494)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- interleukin-11, IL-11 receptor, myocardial fibrosis, renal fibrosis, TGF-β1, fibroblast activation, ERK signaling, autocrine signaling, fibrotic diseases, therapeutic target, organ failure, renal failure, heart failure
- MeSH terms
- Animals, Cardiovascular System, Cells, Cultured, Female, Fibroblasts, Fibrosis, Heart, Humans, Kidney, Male, Middle Aged, Myocardium, Protein Biosynthesis, Interleukin-11, Mice, Knockout, Transgenes, Autocrine Communication, Mice, Interleukin-11 Receptor alpha Subunit, Transforming Growth Factor beta1, Organ Dysfunction Scores
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
